NYMC Faculty Publications
Alternative Donors Extend Transplantation for Patients With Lymphoma who Lack an HLA Matched Donor
Author Type(s)
Faculty
DOI
10.1038/bmt.2014.259
Journal Title
Bone Marrow Transplantation
First Page
197
Last Page
203
Document Type
Article
Publication Date
2-1-2015
Department
Pediatrics
Keywords
Acute Disease, Adolescent, Adult, Age Factors, Aged, Allografts, Chronic Disease, Disease-Free Survival, Female, Follow-Up Studies, Graft vs Host Disease, HLA Antigens, Hematopoietic Stem Cell Transplantation, Histocompatibility Testing, Humans, Lymphoma, Male, Middle Aged, Risk Factors, Survival Rate, Unrelated Donors
Disciplines
Medicine and Health Sciences
Abstract
Alternative donor transplantation is increasingly used for high-risk lymphoma patients. We analyzed 1593 transplant recipients (2000-2010) and compared transplant outcomes in recipients of 8/8 allele HLA-A, -B, -C and DRB1 matched unrelated donors (MUDs; n=1176), 7/8 allele HLA mismatched unrelated donors (MMUDs; n=275) and umbilical cord blood donors (1 or 2 units UCB; n=142). Adjusted 3-year non-relapse mortality of MMUD (44%) was higher as compared with MUD (35%; P=0.004), but similar to UCB recipients (37%; P=0.19), although UCB had lower rates of neutrophil and platelet recovery compared with unrelated donor groups. With a median follow-up of 55 months, 3-year adjusted cumulative incidence of relapse was lower after MMUD compared with MUD (25% vs 33%, P=0.003) but similar between UCB and MUD (30% vs 33%; P=0.48). In multivariate analysis, UCB recipients had lower risks of acute and chronic GVHD compared with adult donor groups (UCB vs MUD: hazard ratio (HR)=0.68, P=0.05; HR=0.35; P< 0.001). Adjusted 3-year OS was comparable (43% MUD, 37% MMUD and 41% UCB). These data highlight the observation that patients with lymphoma have acceptable survival after alternative donor transplantation. MMUD and UCB can extend the curative potential of allotransplant to patients who lack suitable HLA matched sibling or MUD.
Recommended Citation
Bachanova, V., Cairo, M., & Saber, W. (2015). Alternative Donors Extend Transplantation for Patients With Lymphoma who Lack an HLA Matched Donor. Bone Marrow Transplantation, 50 (2), 197-203. https://doi.org/10.1038/bmt.2014.259

Comments
Please see link to outside source for full list of authors.